NASDAQ:ANIK

Anika Therapeutics Stock Insider Trading

Healthcare > Medical - Devices

Buy ANIK

*Your capital is at risk

$14.41

+0.0300 (+0.209%)

At Close: Jun 03, 2026

Anika Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 91.55. In total, the insiders bought 1.7M and sold 79.58K ANIK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	91.55
● Buy	1.7M shares
● Sell	79.58K shares
84% Buy Activity Strong Positive Correlation
Buy Signal High Confidence Apr 30, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 91.55. Partially supported by a positive historical correlation. Confidence increased due to high data reliability score of 100. Supported by overwhelming buy-side pressure (84% buys).

Historical Insider Trades

Date	Type	Person	Role	Amount
May 01, 2026 Buy	Common Stock P-Purchase	Henneman John B Iii Director	Director	5 000 Value: $73.3K
Apr 30, 2026 Buy	Common Stock P-Purchase	Griffin Stephen D. President And CEO	CEO / President	12 200 Value: $149.9K
Mar 19, 2026 Buy	Restricted Stock Unit A-Award	Mcleod Ian SVP, Cao & Treasurer	Officer	11 194 Value: $158.7K
Mar 19, 2026 Buy	Restricted Stock Unit A-Award	Mcleod Ian SVP, Cao & Treasurer	Officer	13 097 Value: $185.7K
Mar 19, 2026 Buy	Premium Priced Stock Appreciation Rights A-Award	Mcleod Ian SVP, Cao & Treasurer	Officer	17 663 Value: $275.5K
Mar 15, 2026 Sell	Common Stock F-InKind	Blanchard Cheryl R Director	Director	12 104 Value: $171.9K
Mar 15, 2026 Buy	Common Stock M-Exempt	Blanchard Cheryl R Director	Director	25 131 Value: $362.1K
Mar 15, 2026 Buy	Common Stock M-Exempt	Colleran David EVP, General Counsel, Corp Sec	Officer	6 449 Value: $92.9K
Mar 15, 2026 Sell	Common Stock F-InKind	Colleran David EVP, General Counsel, Corp Sec	Officer	1 893 Value: $26.9K
Mar 15, 2026 Buy	Restricted Stock Unit M-Exempt	Colleran David EVP, General Counsel, Corp Sec	Officer	6 449 Value: $92.9K
Mar 15, 2026 Buy	Restricted Stock Unit M-Exempt	Blanchard Cheryl R Director	Director	25 131 Value: $362.1K
Mar 15, 2026 Buy	Common Stock M-Exempt	Mcleod Ian SVP, Cao & Treasurer	Officer	2 658 Value: $38.3K
Mar 15, 2026 Sell	Common Stock F-InKind	Mcleod Ian SVP, Cao & Treasurer	Officer	781 Value: $11.1K
Mar 15, 2026 Buy	Restricted Stock Unit M-Exempt	Mcleod Ian SVP, Cao & Treasurer	Officer	2 658 Value: $38.3K
Mar 14, 2026 Buy	Restricted Stock Unit M-Exempt	Blanchard Cheryl R Director	Director	24 519 Value: $353.3K
Mar 14, 2026 Buy	Common Stock M-Exempt	Blanchard Cheryl R Director	Director	24 519 Value: $353.3K
Mar 14, 2026 Sell	Common Stock F-InKind	Blanchard Cheryl R Director	Director	14 728 Value: $209.1K
Mar 14, 2026 Buy	Common Stock A-Award	Blanchard Cheryl R Director	Director	24 520 Value: $353.3K
Mar 14, 2026 Buy	Common Stock M-Exempt	Griffin Stephen D. President And CEO	CEO / President	12 824 Value: $184.8K
Mar 14, 2026 Sell	Common Stock F-InKind	Griffin Stephen D. President And CEO	CEO / President	5 944 Value: $84.4K
Mar 14, 2026 Buy	Restricted Stock Unit M-Exempt	Griffin Stephen D. President And CEO	CEO / President	12 824 Value: $184.8K
Mar 14, 2026 Buy	Common Stock A-Award	Colleran David EVP, General Counsel, Corp Sec	Officer	4 694 Value: $67.6K
Mar 14, 2026 Sell	Common Stock F-InKind	Colleran David EVP, General Counsel, Corp Sec	Officer	4 168 Value: $59.2K
Mar 14, 2026 Buy	Common Stock M-Exempt	Colleran David EVP, General Counsel, Corp Sec	Officer	9 388 Value: $135.3K
Mar 14, 2026 Buy	Restricted Stock Unit M-Exempt	Colleran David EVP, General Counsel, Corp Sec	Officer	9 388 Value: $135.3K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ANIKA THERAPEUTICS INC.

Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis (OA) pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company develops, manufactures, and commercializes products based on hyaluronic acid (HA) technology platform. Its OA pain manageme...

Read Full Profile Here